Determination of noscapine in human plasma using solid-phase extraction and high-performance liquid chromatography

Area of Science:

• Analytical Chemistry
• Pharmacology
• Clinical Chemistry

Background:

• Noscapine is an important antitussive agent with a complex pharmacokinetic profile.
• Accurate quantification of noscapine in biological matrices is essential for clinical and research applications.
• Existing methods for noscapine determination may lack the required sensitivity, specificity, or throughput.

Purpose of the Study:

• To develop and validate a simple, reliable, and high-performance liquid chromatographic (HPLC) method for determining noscapine concentrations in human plasma.
• To establish a robust analytical technique for pharmacokinetic studies and therapeutic drug monitoring of noscapine.

Main Methods:

• Quantitative extraction of noscapine and papaverine (internal standard) from human plasma using an automated off-line solid-phase extraction system with disposable columns.
• Separation of analytes on a reversed-phase column using high-performance liquid chromatography (HPLC).
• Detection and quantification of noscapine and papaverine.

Main Results:

• The developed HPLC method demonstrated high precision and accuracy for noscapine determination in human plasma.
• The validated linear range for the assay was established as 7.2-270 ng/ml.
• No interference from endogenous plasma compounds was observed, indicating high specificity of the method.

Conclusions:

• A validated, simple, and reliable HPLC method is suitable for the accurate quantification of noscapine in human plasma.
• This method provides a valuable tool for pharmacokinetic research and clinical monitoring of noscapine therapy.
• The assay's specificity and accuracy ensure reliable data for understanding noscapine's behavior in the body.